Invention Grant
- Patent Title: C5-spiro iminothiazine dioxides as BACE inhibitors, compositions, and their use
-
Application No.: US15021011Application Date: 2014-09-08
-
Publication No.: US09725468B2Publication Date: 2017-08-08
- Inventor: Jack D. Scott , Wen-Lian Wu , Jared N. Cumming
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Keith D. MacMillan; John C. Todaro
- International Application: PCT/US2014/054455 WO 20140908
- International Announcement: WO2015/038446 WO 20150319
- Main IPC: C07D513/10
- IPC: C07D513/10 ; C07D519/00 ; C07D417/12 ; A61K31/547 ; A61K45/06 ; C07D471/04 ; C07D279/16

Abstract:
In its many embodiments, the present invention provides certain C5-spiro iminothiadiazine dioxide compounds, including compounds Formula (I): or a tautomers and/or stereoisomers thereof, and pharmaceutically acceptable salts of said compounds, said tautomers and said stereoisomers, wherein RL, X, Y, R1A, R1B, R2, R3, m, and RA are as defined herein. The novel compounds of the invention are useful as BACE inhibitors and/or for the treatment and prevention of various pathologies related thereto. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use, including for the possible treatment of Alzheimer's disease, are also disclosed.
Public/Granted literature
- US20160222032A1 C5-SPIRO IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE Public/Granted day:2016-08-04
Information query